Agilent Technologies, Inc. (A) Net Profit Margin: 19.55%
Is Agilent Technologies, Inc.’s net profit margin high or low?
Agilent Technologies, Inc.'s net profit margin of 19.55% is in line with its 5-year average of 17.94%, near the high end of its 5-year range (13.47%–19.80%).
The net profit margin for Agilent Technologies, Inc. (A) is 19.55% as of Wednesday, June 10, 2026. It is above its 12-month average by 1.43% (19.27%).
A Net Profit Margin Chart
A Average Net Profit Margin Chart
A Current vs Average Net Profit Margin Chart
A Net Profit Margin Metrics
NET PROFIT MARGIN
19.55%
NET PROFIT MARGIN AVG TTM
19.27%
NET PROFIT MARGIN AVG 3Y
18.75%
NET PROFIT MARGIN AVG 5Y
17.94%
NET PROFIT MARGIN AVG 10Y
15.54%
NET PROFIT MARGIN AVG 15Y
15.49%
NET PROFIT MARGIN AVG 20Y
16.20%
CURRENT VS TTM AVG
+1.43%
CURRENT VS 3Y AVG
+4.25%
CURRENT VS 5Y AVG
+8.98%
CURRENT VS 10Y AVG
+25.77%
CURRENT VS 15Y AVG
+26.23%
CURRENT VS 20Y AVG
+20.71%
A Competitors' Net Profit Margin
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Agilent Technologies, Inc. (A) | — | 19.55% | 19.27% | 18.75% | 17.94% |
| Zoetis Inc. (ZTS) | $34.20B | 27.79% | 27.55% | 27.17% | 26.57% |
| Centene Corporation (CNC) | $31.94B | -3.25% | -0.70% | 0.29% | 0.65% |
| Medline Inc. (MDLN) | $30.90B | 3.31% | 4.39% | 2.42% | 2.42% |
| IQVIA Holdings Inc. (IQV) | $30.60B | 8.33% | 8.63% | 8.47% | 7.22% |
| Humana Inc. (HUM) | $43.78B | 0.82% | 0.97% | 1.82% | 2.53% |
| IDEXX Laboratories, Inc. (IDXX) | $44.47B | 24.63% | 23.70% | 22.66% | 22.55% |
| DexCom, Inc. (DXCM) | $29.24B | 19.31% | 16.12% | 14.73% | 15.57% |
| Biogen Inc. (BIIB) | $29.00B | 13.92% | 15.03% | 17.95% | 19.29% |
| Veeva Systems Inc. (VEEV) | $26.73B | 28.37% | 27.22% | 24.83% | 24.72% |
Margin Comparison
Operating Margin
21.5%
Net Profit Margin
19.6%
Agilent Technologies, Inc. Net Profit Margin Formula & Definition
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Agilent Technologies, Inc. Net Profit Margin FAQ
- What is the net profit margin for Agilent Technologies, Inc. (A)?
- The net profit margin for A stock is 19.55%.
- Is Agilent Technologies, Inc.'s net profit margin high or low?
- Agilent Technologies, Inc.'s net profit margin of 19.55% is in line with its 5-year average of 17.94%, near the high end of its 5-year range (13.47%–19.80%).
- What is the TTM average net profit margin for Agilent Technologies, Inc. (A)?
- The TTM average net profit margin for A stock is 19.27%.
- What is the 3Y average net profit margin for Agilent Technologies, Inc. (A)?
- The 3Y average net profit margin for A stock is 18.75%.
- What is the 5Y average net profit margin for Agilent Technologies, Inc. (A)?
- The 5Y average net profit margin for A stock is 17.94%.
- What is the 10Y average net profit margin for Agilent Technologies, Inc. (A)?
- The 10Y average net profit margin for A stock is 15.54%.
- What is the 15Y average net profit margin for Agilent Technologies, Inc. (A)?
- The 15Y average net profit margin for A stock is 15.49%.
- What is the 20Y average net profit margin for Agilent Technologies, Inc. (A)?
- The 20Y average net profit margin for A stock is 16.20%.
Agilent Technologies, Inc. Net Profit Margin History
| DATE | NET PROFIT MARGIN |
|---|---|
| 2025-10-31 | 18.75% |
| 2024-10-31 | 19.80% |
| 2023-10-31 | 18.15% |
| 2022-10-31 | 18.31% |
| 2021-10-31 | 19.15% |
| 2020-10-31 | 13.47% |
| 2019-10-31 | 20.74% |
| 2018-10-31 | 6.43% |
| 2017-10-31 | 15.30% |
| 2016-10-31 | 10.95% |
| 2015-10-31 | 9.93% |
| 2014-10-31 | 13.56% |
| 2013-10-31 | 18.59% |
| 2012-10-31 | 16.81% |
| 2011-10-31 | 15.30% |
| 2010-10-31 | 12.56% |
| 2009-10-31 | -0.69% |
| 2008-10-31 | 12.00% |
| 2007-10-31 | 11.77% |
| 2006-10-31 | 66.50% |
| 2005-10-31 | 2.74% |
| 2004-10-31 | 5.14% |
| 2003-10-31 | -46.06% |
| 2002-10-31 | -17.17% |
| 2001-10-31 | 2.00% |
| 2000-10-31 | 8.09% |
| 1999-10-31 | 7.50% |
| 1998-10-31 | 3.23% |
Related Metrics
About Agilent Technologies, Inc.
Agilent Technologies, Inc. delivers specialized, application-focused technologies and services to the global life sciences, diagnostics, and applied chemistry industries. Its Life Sciences and Applied Markets segment provides a comprehensive portfolio of analytical instrumentation. This includes liquid chromatography (LC) and gas chromatography (GC) systems, often integrated with mass spectrometry (MS) for advanced analysis (LC-MS, GC-MS). They also offer inductively coupled plasma mass spectrometry (ICP-MS), atomic absorption (AA), microwave plasma-atomic emission spectrometry (MP-AES), and inductively coupled plasma optical emission spectrometry (ICP-OES) instruments, alongside Raman spectroscopy for material characterization. Beyond spectroscopy, the segment supplies cell analysis solutions such as plate-based assays, flow cytometers, real-time cell analyzers, imaging systems, and microplate readers. Complementing these are various laboratory software, information management platforms, data analytics tools, automated and robotic lab systems, dissolution testing equipment, vacuum technology, and general measurement solutions. The Diagnostics and Genomics division offers cutting-edge tools for genetic and diagnostic research. These encompass arrays designed for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression analysis. This segment also provides target enrichment solutions for next-generation sequencing, along with software for genetic data management and interpretation. Furthermore, it synthesizes custom oligonucleotides. Other significant offerings include immunohistochemistry (IHC), in situ hybridization (ISH), hematoxylin and eosin (H&E) staining, and specialized staining solutions. The division also supplies consumables and software essential for quality control analysis of nucleic acid samples, as well as reagents for turbidimetry and flow cytometry applications. A key area of development for this segment is liquid-based pharmacodiagnostics. Agilent CrossLab, the third segment, focuses on providing essential laboratory consumables and services. Its product range features GC and LC columns, products for sample preparation, custom chemical formulations, and various supplies for laboratory instruments. Complementary services include expert support for startup, ongoing operations, training, compliance, Software-as-a-Service (SaaS) offerings, asset management, and professional consultation. The company's products reach customers through a diverse sales network, including direct sales teams, distributors, resellers, manufacturer's representatives, and its e-commerce platforms. Agilent Technologies, Inc. was established in 1999 and maintains its corporate headquarters in Santa Clara, California.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Padraig McDonnell